DCC and neoplasm: Of note, LAMC2 has been previously identified as a specific marker for tumor budding in multiple tumor types, including CRC18, and we confirmed that its expression correlated with EMP1 mRNA in CRC patient samples (Extended Data Fig. 7e,g).